Theralase Technologies' market value is the price at which a share of Theralase Technologies trades on a public exchange. It measures the collective expectations of Theralase Technologies investors about its performance. Theralase Technologies is trading at 0.19 as of the 2nd of February 2025. This is a 5% down since the beginning of the trading day. The stock's lowest day price was 0.19. With this module, you can estimate the performance of a buy and hold strategy of Theralase Technologies and determine expected loss or profit from investing in Theralase Technologies over a given investment horizon. Check out Theralase Technologies Correlation, Theralase Technologies Volatility and Theralase Technologies Alpha and Beta module to complement your research on Theralase Technologies.
Please note, there is a significant difference between Theralase Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theralase Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theralase Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Theralase Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theralase Technologies' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theralase Technologies.
0.00
01/03/2025
No Change 0.00
0.0
In 30 days
02/02/2025
0.00
If you would invest 0.00 in Theralase Technologies on January 3, 2025 and sell it all today you would earn a total of 0.00 from holding Theralase Technologies or generate 0.0% return on investment in Theralase Technologies over 30 days. Theralase Technologies is related to or competes with Biomerica, Semler Scientific, NanoVibronix, Abbott Laboratories, Stryker, Edwards Lifesciences, and Boston Scientific. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo d... More
Theralase Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theralase Technologies' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theralase Technologies upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theralase Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theralase Technologies' standard deviation. In reality, there are many statistical measures that can use Theralase Technologies historical prices to predict the future Theralase Technologies' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Theralase Technologies. Your research has to be compared to or analyzed against Theralase Technologies' peers to derive any actionable benefits. When done correctly, Theralase Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Theralase Technologies.
Theralase Technologies Backtested Returns
At this point, Theralase Technologies is out of control. Theralase Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0278, which indicates the firm had a 0.0278 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Theralase Technologies, which you can use to evaluate the volatility of the company. Please validate Theralase Technologies' Semi Deviation of 4.63, risk adjusted performance of 0.0316, and Coefficient Of Variation of 3629.37 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Theralase Technologies has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.58, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Theralase Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Theralase Technologies is expected to be smaller as well. Theralase Technologies right now has a risk of 5.57%. Please validate Theralase Technologies jensen alpha, semi variance, price action indicator, as well as the relationship between the maximum drawdown and daily balance of power , to decide if Theralase Technologies will be following its existing price patterns.
Auto-correlation
-0.49
Modest reverse predictability
Theralase Technologies has modest reverse predictability. Overlapping area represents the amount of predictability between Theralase Technologies time series from 3rd of January 2025 to 18th of January 2025 and 18th of January 2025 to 2nd of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theralase Technologies price movement. The serial correlation of -0.49 indicates that about 49.0% of current Theralase Technologies price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.49
Spearman Rank Test
-0.53
Residual Average
0.0
Price Variance
0.0
Theralase Technologies lagged returns against current returns
Autocorrelation, which is Theralase Technologies otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theralase Technologies' otc stock expected returns. We can calculate the autocorrelation of Theralase Technologies returns to help us make a trade decision. For example, suppose you find that Theralase Technologies has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Theralase Technologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theralase Technologies otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theralase Technologies otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theralase Technologies otc stock over time.
Current vs Lagged Prices
Timeline
Theralase Technologies Lagged Returns
When evaluating Theralase Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theralase Technologies otc stock have on its future price. Theralase Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theralase Technologies autocorrelation shows the relationship between Theralase Technologies otc stock current value and its past values and can show if there is a momentum factor associated with investing in Theralase Technologies.
Other Information on Investing in Theralase OTC Stock
Theralase Technologies financial ratios help investors to determine whether Theralase OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theralase with respect to the benefits of owning Theralase Technologies security.